Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Trying to think positive---Gcduck.
15
Nov 16, 2009 05:09PM

Nov 16, 2009 05:30PM
3
Nov 16, 2009 05:34PM
I think some of your answers lie in the response that one of Patriots board of directors gave to an Agora member. All the slap stick comedy has been quite amusing today. My feeling is why waste time reading pump and dump scam artist when we have written communication with a board member? Notice he said it was difficult to find more prior art, not impossible. So the real question is, will Alliacense hold the T3 to the fire or let them off gently? If challenges can persist for years, at what point do they attempt to make an example out of someone? This is why I still stand by my thoughts that our reason for conserving cash is simple, they don't expect to see a flood of it anytime soon. Why read between the lines when a PTSC PR just told us that much? They announced a 40% reduction in PDSG expenses. There was no reason to further mention cash preservation unless, it was really that straight forward. I'm guessing it was. Things are moving slowly and they need to protect capital, plain and simple. It doesn't mean they can't take advantage of other opportunities. It does, however, demonstrate the need for them to balance priorities.
Rank: [?]
Treasurer
Points: [?]
1897
Rating: [?]
Votes: 44 Score: 2.9

FWIW: Email reply from Nick Tredenick

posted on Oct 27, 09 07:13PM
Hi Mr. Tredennick,

I wonder if I could have your thoughts on the recent successes of the MMP Porfolio. Most notably the '336 Patent.

As a long term investor we have been waiting for this recertification; however, it seems there are more petitions to keep the 336' under more reexamination. In your skills and expertise in this field what do you think are the chances of the 336' going under yet again another patent reexamination?

Also, being on the Board of PTSC & TPL - do you plan on merging the two companies or maybe forming a seperate company owned by both? Similar to PDS which harnests all the assets and liabilities stemming from the MMP Portfolio.

I thank you for your time.


Mr. Tredenick's reply:

Hello,

Because the '336 is a broad patent, it is more vulnerable than most patents to the discovery of new prior
art, so it cannot ever really be safe from reexamination. That said, however, it is very difficult to find good prior art. There aren't many data book libraries still around, so time makes the patent safer (but also brings it closer to the end of its life).


With respect to your second question, as a Patriot board member (I'm not on the board at TPL), I'm probably not at liberty to say much, but I doubt that TPL and Patriot will merge and I doubt that they will be held under a joint company. Patriot has started down a path to become a product-based company in order to build a revenue stream that less erratic than the licensing
revenues.


Nick Tredennick
2
Nov 16, 2009 05:36PM
2
Nov 16, 2009 06:13PM
Share
New Message
Please login to post a reply